New Medication for Weight Loss: Tirzepatide (Mounjaro®)
Tirzepatide (Mounjaro) for weight loss is not currently available anywhere in Greater Manchester on the NHS, including GP practices, hospitals, or specialist weight management services.
Tirzepatide (Mounjaro®) will be introduced in stages over three years, Year 1 (2025): Adults with a Body Mass Index (BMI) of 40 or more, and four or more weight-related health conditions.
See the GM website for further updates on the below link: